Page last updated: 2024-09-05

clasto-lactacystin beta-lactone and aminolevulinic acid

clasto-lactacystin beta-lactone has been researched along with aminolevulinic acid in 1 studies

*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]

*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]

Compound Research Comparison

Studies
(clasto-lactacystin beta-lactone)
Trials
(clasto-lactacystin beta-lactone)
Recent Studies (post-2010)
(clasto-lactacystin beta-lactone)
Studies
(aminolevulinic acid)
Trials
(aminolevulinic acid)
Recent Studies (post-2010) (aminolevulinic acid)
850156,4756652,740

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenbaum, L; Grinblat, B; Grünberg-Etkovitz, N; Malik, Z1

Other Studies

1 other study(ies) available for clasto-lactacystin beta-lactone and aminolevulinic acid

ArticleYear
Proteasomal degradation regulates expression of porphobilinogen deaminase (PBGD) mutants of acute intermittent porphyria.
    Biochimica et biophysica acta, 2006, Volume: 1762, Issue:9

    Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Nucleus; Cysteine Proteinase Inhibitors; Cytoplasm; Gene Expression Regulation; Hemin; Humans; Hydroxymethylbilane Synthase; Lactones; Lead Poisoning; Mutant Proteins; Neuroblastoma; Porphyria, Acute Intermittent; Proteasome Endopeptidase Complex; RNA, Messenger; Transfection

2006